 |
|
Carisoprodol as a Drug of Abuse
George S. Rust, MD, MPH;
Robert Hatch, MD, MPH;
John G. Gums, PharmD
Arch Fam Med. 1993;2(4):429-432.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Soma (carisoprodol tablets). In: Physician's Desk Reference. 45th ed. Oradell, NJ: Medical Economics Books; 1991:2283.
2. Fraser HF, Essig CF, Wolbach AB. Evaluation of carisoprodol and phenyramidol for addictiveness. Bull Narc. 1961;13:1-5.
PUBMED
3. Wyller TB, Korsmo G, Gadeholt G. Dependence on carisoprodol (Somadril): a prospective withdrawal study among prisoners [in Norwegian]. Tidsskr Nor Laegeforen. 1991;111:193-195. English abstract.
PUBMED
4. Hollister LE. The prebenzodiazepine era. J Psychoactive Drugs. 1983;15:9-13.
PUBMED
5. Luehr JG, Meyerle KA, Larson EW. Mail-order (veterinary) drug dependence. JAMA. 1990;263:657.
FREE FULL TEXT
6. Morse RM, Chua L. Carisoprodol dependence: a case report. Am J Drug Alcohol Abuse. 1978;5:527-530.
PUBMED
7. Elder NC. Abuse of skeletal muscle relaxants. Am Fam Physician. 1991;44:1223-1226.
PUBMED
8. Today's drugs: carisoprodol. BMJ. 1964;5394:1363-1364.
9. Roszkowski AP. A pharmacological comparison of therapeutically useful centrally-acting skeletal muscle relaxants. J Pharmacol Exp Ther. 1970;129:75-81.
10. Berger FM, Kletzkin M, Ludwig BJ, Margolin S. Review of the pharmacology and efficacy of carisoprodol. Ann N Y Acad Sci. 1960;86:90-107.
PUBMED
11. Cedarbaum JM, Schleifer LS. Drugs for Parkinson's disease, spasticity, and acute muscle spasms. In: Gilman AG, ed. Pharmacological Basis of Therapeutics. 8th ed. Elmsford, NY: Pergamon Press Inc; 1990:481-482. 12. Elenbaas JK. Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm. 1980;37:1313-1323.
ABSTRACT
13. Douglas JF, Ludwig GJ, Schosser A. The metabolic fate of carisoprodol in the dog. J Pharm Exp Ther. 1962;138:21-27.
FREE FULL TEXT
14. Meyer MC, Straughn AB. Meprobamate. J Am Pharm Assoc. 1977;17:173-175.
PUBMED
15. Adams HR, Kerzee T, Morehead CD. Carisoprodol-related death in a child. J Forensic Sci. 1975;20:200-202.
PUBMED
16. Kintz P, Mangin P, Lugnier AA, Chaumont AJ. A rapid and sensitive gas chromatographic analysis of meprobamate and carisoprodol in urine and plasma. J Anal Toxicol. 1988;12:73-74.
PUBMED
17. Katz RL. Sedatives and tranquilizers. N Engl J Med. 1972;286:757-760.
PUBMED
18. Nakamura H, Shimuzu M. Persistence of drug experience in rats formerly dependent on phenobarbital or meprobamate. Neuropharmacology. 1983;22:923-926.
PUBMED
19. Yanagita T, Takahashi S. Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther. 1973;185:307-316.
FREE FULL TEXT
20. Nakamura H, Shimuzu M. Physical dependence on meprobamate after repeated oral administration in rats. Jpn J Pharmacol. 1983;33:1171-1176.
PUBMED
21. Roache JD, Griffiths RR. Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther. 1987;243:978-988.
FREE FULL TEXT
22. Rall TW. Hypnotics and sedatives: meprobamate. In: Gilman AG, ed. Pharmacological Basis of Therapeutics. 8th ed. Elmsford, NY: Pergamon Press Inc; 1990:366-367. 23. Giannini AJ, Price WA, Giannini MC. Contemporary drugs of abuse. Am Fam Phys. 1986;33:207-216.
PUBMED
24. Cowan IC, Mapes RE. Carisoprodol in the management of musculoskeletal disorders. Ann Phys Med. 1963;7:140-143.
25. Hindle TH. Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med. 1972;117:7-11.
PUBMED
26. Boyles WF, Glassman JM, Soyka JP. Management of acute musculoskeletal conditions: thoracolumbar strain or sprain. Today Ther Trends. 1983;1:1-16.
27. Baratta RR. A double-blind comparative study of carisoprodol, propoxyphene, and placebo in the management of low back syndrome. Curr Ther Res. 1976;20:233-240.
PUBMED
28. Deyo RM. Conservative therapy for low back pain: distinguishing useful from useless therapy. JAMA. 1983;250:1057-1062.
FREE FULL TEXT
29. Rolling HE, Glassman JM, Soyka JP. Management of acute musculoskeletal conditions: thoracolumbar strain or sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzaprine hydrochloride. Curr Ther Res. 1983;34:917-927.
30. Miller AR. A comparative study of Parafon Forte tablets and Soma Compound in the treatment of painful skeletal muscle conditions. Curr Ther Res. 1976;19:444-450.
PUBMED
31. Eddy NB, Friebel H, Hahn KJ, Halbach H. Codeine and its alternates for pain and cough relief: alternates for pain relief. Bull World Health Organ. 1969;40:1-53.
PUBMED
32. Data From the Drug Abuse Warning Network (DAWN): Annual Emergency Room Data, 1990. Rockville, Md: National Institute on Drug Abuse; 1991. US Dept of Health and Human Services publication, series I, No. 10-A, p 34. 33. Data From the Drug Abuse Warning Network (DAWN): Annual Data, 1989. Rockville, Md: National Institute on Drug Abuse; 1990. US Dept of Health and Human Services, series I, No. 9, p 53. 34. Goldberg D. Carisoprodol toxicity. Milit Med. 1969;134:597-601.
|
